A blanket prohibition on synthetic drugs in UK prisons has backfired spectacularly, fuelling unprecedented levels of violence and self-harm among inmates, according to groundbreaking research from the University of Sussex.

The 2016 Psychoactive Substances Act, which outlawed so-called “legal highs” across England and Wales, succeeded in reducing availability of New Psychoactive Substances (NPS) by an average of 32 per cent. However, the UK prison drug ban simultaneously triggered a 38 per cent surge in serious assaults—164 additional violent incidents within just four months of implementation.

Deadly Consequences Behind Bars

Ministry of Justice records analysed in the study paint a disturbing picture of unintended harm. Self-directed violence increased by 15 per cent in the weeks following the legislation, resulting in approximately 945 additional self-harm incidents and ten suicides across British prisons.

Dr Rocco d’Este, Associate Professor at the University of Sussex and lead researcher, explains the mechanism behind this crisis: “Reducing the supply of any popular drug tends to inflate prices, and New Psychoactive Substances are no exception. Dealers see more money to be made, whilst fewer inmates can afford to feed their habit, so dealers and increasingly desperate addicts clash in violent power struggles.”

The UK prison drug ban inadvertently created a perfect storm in already overcrowded facilities where mental health problems concentrate. Synthetic cannabis, stimulants like mephedrone, and psychedelic substances such as methoxetamine remained widely available despite prohibition—but at dramatically inflated prices.

Economic Pressures Fuel Prison Violence

Before the ban, synthetic cannabis could be purchased online for £84 per ounce or £3 per gram. Inside British prisons, dealers resold the same substance for approximately £100 per gram, using contraband mobile phones and digital banking to facilitate transactions.

The UK prison drug ban drove prices up by an estimated 80 to 300 per cent, according to multiple studies including the Home Office’s 2018 policy impact assessment. This price explosion made NPS habits unsustainable for addicted prisoners, triggering withdrawal symptoms and desperate behaviour.

“Addicts withdrawing from synthetic cannabis can experience acute psychosis, hallucinations and paranoid delusions,” Dr d’Este warns. “Cutting drug supply in prisons where NPS addiction is rife without offering effective treatment adds another element of danger to understaffed institutions.”

Evidence-Based Analysis

The Sussex University team examined 96 prisons across England and Wales over forty months, comparing violence and self-harm incidents before and after the 2016 legislation. By creating a control group of prisons with lower NPS prevalence, researchers confirmed that the violence surge was directly attributable to the UK prison drug ban rather than other factors.

Peter Clarke, then Chief Inspector of Prisons, described 2016 as witnessing “the worst drug-related problems ever seen in prisons” with “debt, bullying and violence… making it difficult for normal prison life to continue.”

Long-Term Societal Costs

The research team emphasizes that failing to address addiction and violence within British prisons carries significant consequences beyond institutional walls. Studies demonstrate that violent prison conditions increase reoffending rates, creating a cycle that perpetuates crime and drains public resources.

“We need to start addressing demand as well as supply by delivering proper medical treatment and improving living conditions for inmates,” Dr d’Este urges. “Continuing to ignore the addiction and violence endemic to our prisons will lead to more crime on our streets, and more taxpayer money going on prison sentences in future.”

The findings highlight a critical lesson for policymakers: supply-side interventions like the UK prison drug ban require complementary demand-side measures. Effective addiction treatment, mental health services, and improved rehabilitation programmes are essential to protect both institutional safety and public wellbeing.

Rather than simply incarcerating individuals and releasing them in worse condition, evidence suggests comprehensive approaches that treat underlying substance dependencies offer better outcomes for prisoners, staff, and communities alike.

Source: dbrecoveryresources